Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kappa receptor bivalent ligands.

Xuemei Peng1, John L Neumeyer

  • 1Alcohol and Drug Abuse Research Center, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02478, USA.

Current Topics in Medicinal Chemistry
|February 20, 2007
PubMed
Summary

Bivalent ligands targeting kappa opioid receptors are valuable research tools. Development of novel kappa antagonists like GNTI and JDTic offers potential for new analgesics with improved side effect profiles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LncPTEC mediated homocysteine accumulation elevates oxidative stress via UBQLN1-dependent MTHFD1 ubiquitination in DKD.

Cell death & disease·2026
Same author

Identifying NOTCH signaling-specialized hematopoietic supportive subpopulation from mesenchymal stem cells.

Stem cell research & therapy·2026
Same author

Structural and dynamic insights into SPDT for phosphorus allocation in rice.

Science China. Life sciences·2026
Same author

Characterization of [<sup>3</sup>H]MCL-524, a Potent Dopamine D<sub>2</sub> <sup>high</sup> Receptor Agonist.

ACS omega·2026
Same author

Transoral Endoscopic Plasma Resection for Diagnosis and Management of Laryngeal Inflammatory Myofibroblastic Tumor: A Case Report.

Ear, nose, & throat journal·2026
Same author

Efficacy and Safety of Hospital-at-Home versus Traditional Hospital Care in Older Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Gerontology·2026

Area of Science:

  • Pharmacology
  • Neuroscience
  • Medicinal Chemistry

Background:

  • Bivalent ligands for kappa opioid receptors, including agonists and antagonists like norBNI and BNI, are crucial for understanding receptor characteristics.
  • While bivalent ligands show analgesic potential, none are currently in clinical use.

Purpose of the Study:

  • To develop more potent and selective kappa opioid receptor antagonists.
  • To explore novel bivalent ligands for potential analgesic applications with reduced adverse effects.
  • To utilize bivalent ligands as probes for studying kappa opioid receptor oligomerization.

Main Methods:

  • Structure-activity relationship (SAR) studies.
  • Molecular modeling.
  • Synthesis and pharmacological evaluation of novel homo and hetero bivalent ligands.

Main Results:

  • Development of a potent and selective kappa antagonist, 5'-guanidinylnaltrindole (GNTI).
  • Creation of novel bivalent ligands with mixed kappa/micro or kappa/delta opioid receptor affinity.
  • Identification of JDTic as a unique kappa antagonist for receptor characterization.

Conclusions:

  • Bivalent ligands are essential tools for kappa opioid receptor research.
  • Novel bivalent ligands demonstrate potential as future analgesics with improved safety profiles.
  • These ligands can also serve as probes for investigating receptor organization and oligomerization.

Related Experiment Videos